Facebook
Twitter
Telegram
Report an ErrorIterum Therapeutics Financial Statements 2011-2024 | ITRM
Annual Financial Statements Iterum Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
20 M | 13.8 M | 3.74 M | 2.26 M | 36.4 M | 96.7 M | - | - | - | - | - | - | - |
Shares |
13 M | 12.2 M | 10.9 M | 1.6 M | 14.5 M | 14.4 M | - | - | - | - | - | - | - |
Historical Prices |
1.54 | 1.13 | 0.343 | 1.41 | 2.32 | 6.14 | - | - | - | - | - | - | - |
Net Income |
-38.4 M | -44.4 M | -91.6 M | -52 M | -103 M | -77.1 M | -29.4 M | -13.5 M | - | - | - | - | - |
Revenue |
- | - | - | - | 37 K | 869 K | 508 K | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-47.5 M | -30.4 M | -24.5 M | -32.1 M | -102 M | -76.6 M | -29.5 M | -13.4 M | - | - | - | - | - |
Interest Expense |
82 K | 503 K | 195 K | 213 K | 196 K | 401 K | 216 K | 8 K | - | - | - | - | - |
EBITDA |
-47.4 M | -30.3 M | -24.1 M | -32 M | -102 M | -76.4 M | -29.4 M | -13.4 M | - | - | - | - | - |
Operating Expenses |
47.5 M | 30.4 M | 24.5 M | 32.1 M | 102 M | 77.4 M | - | - | - | - | - | - | - |
General and Administrative Expenses |
7.48 M | 12.8 M | 13.8 M | 11.1 M | 11.3 M | 8.78 M | 4.46 M | 3.26 M | - | - | - | - | - |
All numbers in USD currency
Quarterly Income Statement Iterum Therapeutics
| 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Shares |
15.4 M | 13 M | 12.9 M | 12.7 M | - | 12.2 M | 12.2 M | 12.2 M | - | 12.2 M | 180 M | 122 M | 40.6 M | 20.4 M | 15.6 M | 14.9 M | 14.9 M | 14.6 M | 14.3 M | 14.3 M | 14.1 M | 14 M | 7.09 M | 198 K | - | 185 K | 159 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income |
-7.1 M | -3.88 M | -12.2 M | -9.89 M | - | -29.1 M | -6.74 M | -3.5 M | - | 3.74 M | 7.8 M | -98.9 M | -11.2 M | -52 M | -52 M | -52 M | -23.6 M | -103 M | -103 M | -103 M | -24.3 M | -77.1 M | -77.1 M | -77.1 M | - | -29.4 M | -29.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 37 K | 37 K | 37 K | 239 K | 254 K | 185 K | 191 K | - | 159 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cost of Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gross Profit |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Income |
-6.16 M | -16.7 M | -10.8 M | -8.53 M | - | -7.03 M | -8.05 M | -7.37 M | - | -4.87 M | -6.99 M | -5.85 M | - | -6.34 M | -8.25 M | -12.9 M | - | -31 M | -27.4 M | -20.5 M | - | -25 M | -15.4 M | -12.2 M | - | -8.3 M | -6.41 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Interest Expense |
-17 K | 70 K | 50 K | 41 K | - | 175 K | 269 K | 162 K | - | 33 K | 93 K | 41 K | - | 68 K | -3 K | -38 K | - | 48 K | 32 K | 124 K | - | 328 K | -177 K | 61 K | - | 90 K | 165 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-6.16 M | - | - | -8.52 M | - | -6.96 M | -8 M | -7.34 M | - | -4.54 M | -6.77 M | -5.81 M | - | -6.17 M | -8.09 M | -12.7 M | - | -30.8 M | -27.2 M | -20.3 M | - | -24.8 M | -15.3 M | -12.1 M | - | -8.23 M | -6.35 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Expenses |
6.16 M | 16.7 M | 10.8 M | 8.53 M | - | 7.03 M | 8.05 M | 7.37 M | - | 4.87 M | 6.99 M | 5.85 M | 4.64 M | 6.34 M | 8.25 M | 12.9 M | 23.2 M | 31 M | 27.4 M | 20.5 M | 24.2 M | 25.2 M | 15.6 M | 12.4 M | - | 8.46 M | 6.41 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
General and Administrative Expenses |
2.19 M | 1.83 M | 1.86 M | 2.1 M | - | 2.68 M | 4.07 M | 3.93 M | - | 3.03 M | 4.27 M | 3.4 M | - | 2.4 M | 3.21 M | 3.15 M | - | 2.93 M | 2.94 M | 3.12 M | - | 2.66 M | 1.89 M | 1.52 M | - | 1.02 M | 1.12 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency